A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma

Ahmad A. Tarhini, Michael Millward, Paul Mainwaring, Richard Kefford, Ted Logan, Anna Pavlick, Steven J. Kathman, Kevin H. Laubscher, Mohammed M. Dar, John M. Kirkwood

Research output: Contribution to journal › Article › peer-review